This finding was corroborated by fluorescence imaging and tumor body photographs on day 79, which also showed weaker tumor growth in the MAT1A-knockdown group (p < 0.05) (Supplementary Fig. S1B, C). This evidence concerns the gene MAT1A and neoplasm.